Dr. Matthew Baker, MD
What this data tells you about Dr. Baker
Dr. Matthew Baker is a neurology in Naples, FL, with 19 years in practice. Based on federal Medicare data, Dr. Baker performed 25,620 Medicare services across 1,006 unique beneficiaries.
Between the years covered by Open Payments, Dr. Baker received a total of $1,454,636 from 77 pharmaceutical and/or device companies across 2380 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Baker is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Ocrelizumab infusion (Ocrevus) for MS | 24,000 | $47 | $121 |
| Office visit, established patient, complex (40-54 min) | 675 | $131 | $474 |
| Office visit, established patient (30-39 min) | 572 | $91 | $334 |
| Administration of chemotherapy into vein, 1 hour or less | 165 | $103 | $614 |
| Administration of chemotherapy into vein, each additional hour | 60 | $23 | $119 |
| Mri scan of brain before and after contrast | 59 | $89 | $278 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 40 | $4 | $41 |
| New patient office visit, complex (60-74 min) | 30 | $156 | $585 |
| Injection of additional new drug or substance into vein | 19 | $12 | $96 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for neurology in FL.
Geographic Context
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Baker is a mixed practice specialist, with above-average Medicare volume (top 4% in FL), and high industry engagement (speaking/promotional, top 0%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Baker experienced with ocrelizumab infusion (ocrevus) for ms?
Does Dr. Baker receive payments from pharmaceutical companies?
How do Dr. Baker's costs compare to other neurologys in Naples?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology